暂无推荐供应商。我要出现这里
化源商城直购
[1]. Zhang H, et al. Pharmacokinetics and pharmacodynamics of rongliflozin, a novel selective inhibitor of sodium-glucose co-transporter-2, in people with type 2 diabetes mellitus. Diabetes Obes Metab. 2020 Feb;22(2):191-202.